IP Verse

Treatment Of Solid Brain Tumours With A Rapamycin Derivative

Patent No. EP2762140 (titled "Treatment Of Solid Brain Tumours With A Rapamycin Derivative") was filed by Novartis on Feb 18, 2002. The application was issued on Mar 22, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ETHYPHARMDec 22, 2017LLR
GENERICS UKDec 22, 2017ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2762140

NOVARTIS
Application Number
EP14164565A
Filing Date
Feb 18, 2002
Status
Revoked
Dec 16, 2020
Publication Date
Mar 22, 2017
External Links
Slate, Register , Google Patents